Oxford/AstraZenica vaccine takes next steps towards approval

As half a million of the most vulnerable people in the UK and NHS and other key workers have had their first dose of the Pfizer/BioNTech vaccination against Coronavirus, the full data package for the Oxford/AstraZenica has now been submitted to the Medicines and Healthcare products Regulatory Agency (MHRA) for approval.

Obviously, and just as Prizer and BioNTech did with the first vaccine Oxford Uni and AstraZenica have been submitting data on their extensive clinical trials to MHRA as it came in, so the regulator will not be in the position of having to read through the whole dataset from the beginning before they can make a decision.

However, I presume this means that Oxford and AstraZenica think they now have the data from a complete clinical trial to prove the vaccine is safe and effective. Hopefully MHRA will be able to confirm that the data does prove this and give approval.

Another vaccine will be great news - if we have two different vaccines available there is that much less risk that either the new strain of COVID-19 recently discovered and sometimes referred to as B.1.1.7, or any other new strain of the Coronavirus, will be resistant to both. 


Popular posts from this blog

Nick Herbert on his visit to flood hit areas of Cumbria

Quotes of the day 19th August 2020

Quote of the day 24th July 2020